Association of PPARG genotypes with biochemical markers in type 2 diabetes mellitus among a Nigerian population
Background: This study investigated the role of PPARG genetic variants in type 2 diabetes mellitus complications among individuals in Ekiti State, Nigeria. The focus was on understanding how these genetic variants may influence biochemical markers and, consequently, the risk of complications. Method...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Golestan University Of Medical Sciences
2024-12-01
|
| Series: | Journal of Clinical and Basic Research |
| Subjects: | |
| Online Access: | http://jcbr.goums.ac.ir/article-1-464-en.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Background: This study investigated the role of PPARG genetic variants in type 2 diabetes mellitus complications among individuals in Ekiti State, Nigeria. The focus was on understanding how these genetic variants may influence biochemical markers and, consequently, the risk of complications.
Methods: We recruited 74 diabetic patients and 20 controls from a university teaching hospital. Ten milliliters of whole blood samples were collected by venipuncture and divided into two 5-milliliter aliquots. One aliquot was placed in an EDTA bottle, and the other in a fluoride oxalate bottle, before centrifugation to obtain plasma. PPARG genotyping and biochemical marker analyses, including Cystatin C, ALT, CK-MB, and IL-10, were performed.
Results: Significant differences in PPARG genotype distribution were observed, with the GG genotype being more common in diabetic individuals. Diabetic subjects showed elevated Cystatin C, ALT, and CK-MB levels, along with reduced IL-10, particularly among females. PPARG genotypes were associated with several biochemical markers, notably Cystatin C (p = 0.002), ALT (p = 0.030), and FBS (p = 0.017).
Conclusion: These findings highlight a complex relationship between PPARG genotypes and the pathophysiology of diabetes in the Nigerian population, emphasizing the potential for personalized medicine approaches in type 2 diabetes mellitus management. |
|---|---|
| ISSN: | 2538-3736 |